Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis in malignant gliomas

K H Plate1, W Risau

  • 1Neurozentrum, Albert-Ludwigs Universität, Freiburg, Germany.

Glia
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Glioma progression involves increased angiogenesis, driven by vascular endothelial growth factor (VEGF) and its receptors. These factors are reactivated in tumors after being suppressed in adult brains, suggesting therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma.

British journal of cancer·2025
Same author

CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival.

Acta neuropathologica communications·2018
Same author

Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity.

Neuropathology and applied neurobiology·2013
Same author

Serum GFAP is a diagnostic marker for glioblastoma multiforme.

Brain : a journal of neurology·2007
Same author

Xanthogranuloma of the sellar region.

Acta neurochirurgica·2005
Same author

Spinocerebellar ataxia type 2 with glial cell cytoplasmic inclusions.

Journal of neurology, neurosurgery, and psychiatry·2004
Same journal

A Super-Resolution Approach for Astrocyte-Specific Molecular Imaging Reveals the Nanoscale Distribution of Monoacylglycerol Lipase, the Metabolic Node Between Endocannabinoid and Prostaglandin Signaling.

Glia·2026
Same journal

Blocking CK2α-Bclaf1 Preserves Oligodendrocytes After Neonatal Hypoxic Injury.

Glia·2026
Same journal

Molecular Characteristics and Differentiation Control Mechanisms of Bergmann Glia-Like Progenitors in the Postnatal Mouse Cerebellum.

Glia·2026
Same journal

Alzheimer's Protection by PLCγ2 Compacts Plaques, Redistributes Microglia, and Protects Synapses in App<sup>NL</sup> <sup>-G-F</sup> Mice.

Glia·2026
Same journal

Single-Nucleus Multiomic Analysis Reveals Immune-Metabolic Reprogramming Consistent With Maladaptive Trained Immunity in HIV-Associated Neurocognitive Disorders.

Glia·2026
Same journal

Plasma Membrane Remodeling During Microglial Activation: A Hypothesis Linking Microglial Shape and Lipid Droplet Formation.

Glia·2026
See all related articles

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Glioma progression is characterized by increased angiogenesis, with varying vascularity between low-grade and high-grade tumors.
  • Understanding the molecular regulation of angiogenesis is crucial for developing effective glioma treatments.

Purpose of the Study:

  • To investigate the expression of vascular endothelial growth factor (VEGF) and its receptors (VEGFR-1, VEGFR-2) in normal brain development and glioma angiogenesis.
  • To elucidate the molecular mechanisms controlling VEGF and VEGFR signaling in glioma progression.

Main Methods:

  • Studied the expression patterns of VEGF, VEGFR-1, and VEGFR-2.
  • Compared expression during embryonic brain development, normal adult brain, and glioma progression.

Related Experiment Videos

Main Results:

  • VEGF signaling is transiently regulated during embryonic development, switched off in adult brains, and reactivated during glioma progression.
  • VEGF is upregulated in tumor cells, while VEGFR-1 and VEGFR-2 are upregulated in the host vasculature.

Conclusions:

  • Glioma angiogenesis is controlled by a paracrine mechanism involving VEGF and its receptors.
  • The reactivation of VEGF signaling in tumors presents a potential therapeutic target for glioma treatment.